FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070434 [Registered on: 10/07/2024] Trial Registered Prospectively
Last Modified On: 08/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [prophylactic use of Glycerin enema versus Glycerin suppository versus no intervention]  
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   To study the effect of use of prophylactic Glycerin enema versus Glycerin suppository versus no intervention on time required to reach full feeds in very low birth weight neonates 
Scientific Title of Study   An open-label randomized controlled trial to compare the time to reach full enteral feeds between the use of prophylactic Glycerin enema and Glycerin suppository and standard of care in neonates less than 1500 grams at birth 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prasoon Bansal 
Designation  DM, senior resident 
Affiliation  Bharati Vidyapeeth Deemed University Medical College, Pune 
Address  NICU, second floor, Bharati Hospital, Dhankawadi, Pune Pune MAHARASHTRA 411043 India

Pune
MAHARASHTRA
411043
India 
Phone  7620432218  
Fax    
Email  prasoonb999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nandini Malshe 
Designation  Professor, daprtment of neonatology, Bharati vidyapeeth deemed to be university, Pune 
Affiliation  Bharati Vidyapeeth Deemed University Medical College, Pune 
Address  NICU, second floor, Bharati Hospital, Dhankawadi, Pune Pune MAHARASHTRA 411043 India

Pune
MAHARASHTRA
411043
India 
Phone  9822850716  
Fax    
Email  malshenandini@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prasoon Bansal 
Designation  DM, senior resident 
Affiliation  Bharati Vidyapeeth Deemed University Medical College, Pune 
Address  NICU, second floor, Bharati Hospital, Dhankawadi, Pune Pune MAHARASHTRA 411043 India

Pune
MAHARASHTRA
411043
India 
Phone  7620432218  
Fax    
Email  prasoonb999@gmail.com  
 
Source of Monetary or Material Support  
Bharati Vidyapeeth Deemed University Medical College Dhankwadi,Pune, India- 411043 
 
Primary Sponsor  
Name  Bharati Vidyapeeth Deemed University Medical College Pune 
Address  NICU, second floor, Bharati Hospital and research Centre, Dhankawadi, Pune, India 411043 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prasoon Bansal  Bharati hospital and research Centre, Pune  NICU , second floor, Hospital building, Bharati hospital and research Centre, Dhankawadi Pune, India - 411043
Pune
MAHARASHTRA 
7620432218

prasoonb999@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bharati Vidyapeeth Deemed University Medical College Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: PCS||,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Glycerin enema  1st arm of neonates will be prophylactically administered glycerin enema using 6 Fr infant feeding tube inserted upto 6 cm in rectum starting at 24 hours of life and monitored time to reach full enteral feeds 
Intervention  Glycerin suppository  2nd arm of neonates will be prophylactically administered 1 gram Glycerin suppository divided vertically in half starting at 24 hours of life and monitored for time to reach full enteral feeds 
Comparator Agent  no intervention (standard of care)  3rd arm of neonates will not be given any intervention and monitored for time to reach full enteral feeds 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  1.00 Day(s)
Gender  Both 
Details  neonates admitted to neonatal intensive care unit (NICU) on day-1 of life with birthweight less than 1500 grams at birth. 
 
ExclusionCriteria 
Details  1)Congenital anomalies
2)Major surgery within 48 h of birth.
3)Neonate with APGAR less than 7 at 5 minutes of life.
4)Hemodynamically unstable neonate- e.g those requiring inotrope support 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The time (in days) required to achieve full enteral feeds (enteral feed volume of 150 ml/kg/day
for atleast 24 hours) between the use of prophylactic glycerin enema, glycerin suppository with
standard of care in neonates less than 1500 grams at birth. 
The time (in days) required to achieve full enteral feeds (enteral feed volume of 150 ml/kg/day
for atleast 24 hours) between the use of prophylactic glycerin enema, glycerin suppository with
standard of care in neonates less than 1500 grams at birth. 
 
Secondary Outcome  
Outcome  TimePoints 
1)To compare time required to regain birth weight between the use of prophylactic glycerin
enema, glycerin suppository with standard of care in neonates less than 1500 grams at
birth.
2)To compare adverse events like feeding intolerance, necrotizing enterocolitis (Modified
Bell’s classification) between the use of prophylactic glycerin enema, glycerin
suppository with standard of care in neonates less than 1500 grams at birth.
3)To compare age at the time of discharge from hospital between the use of prophylactic
glycerin enema, glycerin suppository with standard of care in neonates less than 1500
grams at birth. 
1)time required to regain birth weight
2) time till discharge from NICU
3)time till discharge from NICU 
 
Target Sample Size   Total Sample Size="112"
Sample Size from India="112" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   19/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Enteral nutrition optimization in Very Low Birthweight neonates is challenging due to feed intolerance. Delayed meconium passage is more common in more premature infants, leading to obstructed deep intestinal segments and a delay in achieving full feeds.Glycerin laxatives stimulate passage of meconium by acting as an osmotic dehydrating agent and increasing osmotic pressure in the gut; they stimulate rectal contraction, potentially reducing the incidence of feeding intolerance.The Glycerin laxatives are among the commonly used strategies in preterm infants to treat or prevent feeding intolerance and to facilitate normal stooling pattern. However the evidence on the use of Glycerin laxatives in promoting feeding tolerance is limited. In this study, we aim to do a three-arm randomized controlled trial to compare the efficacy of Glycerin enema versus Glycerin suppository versus standard of care in reducing the time to reach full enteral feeds in neonates less than 1500 grams at birth. We hypothesize that there would be no difference in time to reach full enteral feeds in either of the study groups.
 
Close